UNC Project is based at Tidziwe Centre on the campus of Kamuzu Central Hospital in Lilongwe. “Tidziwe” is a Chichewa word which means, “We should find out.” This two-story, 17,500 sq ft building includes outpatient and research exam and counseling rooms, a state-of-the-art laboratory, a medical library with satellite web connections supporting journal access, a lecture hall and classroom with teleconferencing capacity, a data management area with remote and local data entry capacity, secure data storage space, a pharmacy and dispensary, and administrative and community outreach offices.
Research studies being conducted at Tidziwe Centre include those under the Microbicide Trials Network (MTN), Adult Clinical Trials Group (AACTG) and HIV Prevention Trials Network (HPTN).
Kamuzu Central Hospital
UNC Project also administers a study site of the Center for HIV/AIDS Vaccine Immunology (CHAVI) at Kamuzu Central Hospital’s sexually transmitted infections (STI) clinic. The STI clinic has a clinical and research area, examination and counseling rooms and an auxiliary laboratory.
George Joaki Centre
Named for a former lab director at UNC Project, George Joaki Centre is located at the Area 18 Health Centre and is currently conducting the RTS’s Malaria Vaccine Trial V (MAL-055) coordinated by the PATH Malaria Vaccine Initiative.
Bwaila Hospital in Lilongwe is home to UNC Project’s prevention of mother-to-child transmission of HIV (PMTCT) programs. UNC Project provides PMTCT technical support in all health centers in Lilongwe District, including Bwaila Hospital. Bwaila Hospital was the study site for the Breastfeeding, Antiretroviral and Nutrition (BAN) study, a five-year study funded by the U.S. Centers for Disease Control. Results from this study were published in the New England Journal of Medicine in June 2010.